although
canin
herpesviru
chv
also
refer
canin
herpesviru
canid
herpesviru
neonat
herp
genit
herp
ocular
herp
infect
relat
diseas
recogn
sinc
earli
resurg
interest
variou
clinic
manifest
viru
make
review
time
variou
form
chvassoci
infect
list
tabl
case
infect
directli
relat
clinic
symptom
acut
neonat
viremia
result
puppi
mortal
system
viremia
naiv
pregnant
femal
result
fetal
death
abort
mummif
ocularrespiratori
diseas
dog
variou
age
rang
chang
within
past
decad
abil
detect
viru
subclin
state
allow
much
clearer
understand
import
subpopul
dog
carriershedd
adult
dog
chvlatent
infect
dog
anim
popul
work
increas
sensit
antibodybas
serolog
assay
nucleic
acidbas
polymeras
chain
reaction
pcr
assay
increas
level
clinic
inquiri
regard
chv
well
canin
infecti
microorgan
addit
recogn
chv
adult
carrier
gener
popul
new
momentum
allow
clinician
screen
dog
undergo
author
noth
disclos
immunosuppress
regimen
therapi
variou
dermatolog
condit
well
dog
treat
variou
cancer
review
provid
brief
overview
reproduct
aspect
chv
diseas
bring
togeth
current
literatur
document
involv
chv
adult
dog
respiratori
ocular
diseas
consist
alpha
herpesvirus
chv
predilect
pregnant
dog
neonat
puppi
earli
report
focus
effect
chv
variou
reproduct
paramet
dog
part
due
sever
clinic
symptom
profound
patholog
effect
review
anvik
acut
neonat
viremia
system
infect
pregnant
femal
regard
import
diseas
outcom
chv
infect
emphasi
time
recognit
clinic
symptom
rapid
diagnosi
sinc
commerci
vaccin
current
avail
prevent
chvinduc
diseas
becom
paramount
understand
clinic
featur
chv
infect
see
tabl
incorpor
knowledg
sound
manag
practic
minim
effect
reproduct
effici
puppi
surviv
mention
previous
primari
focu
earlier
literatur
chv
infect
infect
may
occur
pregnanc
may
acquir
puppi
first
week
life
key
featur
phase
pregnant
femal
puppi
immunolog
chv
therefor
highli
suscept
diseas
puppi
may
acquir
infect
utero
passag
birth
canal
contact
oronas
secret
dam
contact
shedder
human
may
serv
fomit
viru
attend
adult
carriershedd
dog
proceed
nurseri
set
without
proper
disinfect
neonat
puppi
younger
week
highest
risk
fatal
system
diseas
dog
older
week
rel
resist
diseas
still
becom
infect
viru
infect
older
dog
gener
acquir
via
aerosol
replic
occur
nasopharynx
tonsil
retropharyng
bronchial
lymph
node
respiratori
site
becom
import
aspect
ecolog
viru
respiratori
ocular
clinic
outcom
cover
subsequ
section
although
neonat
infect
regard
common
utero
infect
chv
may
occur
infertil
abort
stillborn
weak
pup
report
mortal
rate
usual
approach
fetal
puppi
may
clinic
manifest
report
dam
passiv
immun
acquir
dam
appear
primari
biolog
import
surviv
infect
pup
puppi
nurs
chvseroneg
dam
usual
develop
fatal
multisystem
diseas
puppi
suckl
chvseroposit
dam
remain
asymptomat
still
becom
infect
chv
usual
recov
oropharyng
region
diseaseresist
pup
gener
accept
matern
antibodi
andor
immun
lymphocyt
acquir
milk
explain
natur
infect
dam
diseas
litter
usual
give
birth
normal
litter
subsequ
pregnanc
sinc
chv
one
canin
viral
infect
proceed
fatal
diseas
commerci
vaccin
routin
avail
becom
necessari
infect
manag
prevent
reproduct
diseas
literatur
focus
aspect
viru
relationship
host
immun
carrierspread
dynam
within
popul
suscept
dog
risk
factor
associ
chv
infect
reproduct
diseas
intens
studi
past
year
studi
use
variou
diagnost
assay
includ
serolog
viru
isol
polymeras
chain
reaction
pcr
studi
provid
valuabl
inform
control
chvassoci
reproduct
diseas
ie
infertil
abort
stillbirth
neonat
mortal
tabl
list
risk
factor
studi
whether
associ
reproduct
diseas
factor
identifi
posit
correl
diseas
breed
kennel
age
mate
experi
cycl
stage
concurr
kennel
cough
kennel
size
breed
manag
hygien
underli
risk
aforement
factor
chv
infect
immun
suscept
dog
led
strategi
natur
immun
via
contact
adult
dog
suscept
femal
dog
prebreed
screen
femal
dog
chv
infect
serolog
andor
pcr
prior
breed
use
defin
quarantin
period
pregnant
dog
unknown
chv
infect
statu
agerisk
immunolog
strategi
use
clinician
client
focu
suscept
time
period
diseas
time
encompass
pregnant
femal
last
week
prior
whelp
puppi
week
post
whelp
understand
constitut
rational
danger
period
primari
contribut
risk
factor
allow
chv
infect
diseas
kennel
size
hygien
kennel
cough
import
spread
retent
chv
highrisk
dog
popul
controversi
chv
signific
contributor
kennel
cough
syndrom
ongo
debat
see
subsequ
section
respiratoryocular
infect
note
chv
initi
report
respiratori
pathogen
earli
reproduct
pathogen
data
ronss
cowork
support
content
chv
primarili
maintain
spread
among
dog
multidog
environ
respiratori
infect
diseas
outcom
chv
infect
age
depend
naiv
puppi
less
month
age
natur
experiment
infect
chv
may
highli
fatal
natur
exposur
pup
occur
ingest
inhal
viru
contain
materi
primari
replic
site
nasal
mucosa
pharynx
tonsil
system
spread
viru
enhanc
cellassoci
viremia
patholog
induc
chv
lung
newborn
pup
depict
fig
experiment
infect
older
dog
month
older
chv
result
mild
rhiniti
pharyng
symptom
tracheobronch
produc
follow
experiment
inocul
chv
isol
natur
infect
dog
experiment
infect
pup
induc
mild
rhiniti
pharyng
viru
replic
demonstr
upper
respiratori
tract
although
chv
isol
dog
upper
respiratori
diseas
reproduct
kennel
cough
rare
report
thompson
cowork
report
aerosol
exposur
dog
caus
necrot
rhiniti
broncheointerstiti
pneumonia
multifoc
alveolar
necrosi
sever
diseas
occur
chv
infect
dog
immunosuppress
case
gener
chv
infect
dog
normal
immun
system
document
recent
gadsden
bj
langohr
im
mae
r
fatal
herpesvir
infect
adult
dog
submit
public
sever
lesion
seen
liver
histolog
lesion
observ
lung
dog
present
fig
infect
rate
base
serolog
studi
high
enough
explain
entri
chv
multidog
environ
either
activ
infect
result
reactiv
latent
viru
environ
associ
natur
pharmacolog
induc
immunosuppress
belgium
seropreval
adult
dog
found
rijsewijk
colleagu
report
seropreval
netherland
read
field
use
antibodi
detect
elisa
found
seropreval
unit
kingdom
japan
seropreval
recent
report
sinc
chv
regard
weak
immunogen
antibodybas
survey
probabl
underrepresent
true
infect
rate
dog
popul
canin
infecti
respiratori
diseas
cird
commonli
seen
rescu
center
board
kennel
veterinari
hospit
affect
dog
dri
cough
limit
durat
complic
case
bronchopneumonia
seen
fatal
multipl
infecti
agent
play
role
induct
cird
canin
parainfluenza
viru
bordetella
bronchiseptica
frequent
involv
canin
distemp
canin
adenoviru
type
associ
cird
routin
detect
due
part
effect
vaccin
popul
immun
fairli
high
canin
influenza
canin
respiratori
coronaviru
recent
canin
pneumoviru
emerg
compon
cird
ad
complex
diseas
syndrom
although
chv
infect
document
multidog
environ
etiolog
role
cird
still
assess
longitudin
studi
virus
associ
cird
rescu
center
unit
kingdom
chv
found
tracheal
sampl
examin
lung
sampl
infect
chv
seen
week
entri
associ
sever
respiratori
sign
delay
detect
viru
pcr
corrobor
serolog
data
also
indic
chv
infect
occur
later
time
point
possibl
explan
offer
detect
sever
case
possibl
latent
chv
could
reactiv
result
stress
induc
primari
cird
episod
trigger
viral
bacteri
agent
viru
sourc
determin
author
specul
genet
differ
chv
strain
would
detect
sourc
viru
result
reactiv
latent
viru
differ
dog
report
howev
chv
strain
show
low
sequenc
variabl
erl
brownli
monitor
dog
train
center
unit
kingdom
year
dog
vaccin
leptospira
interrogan
tonsillar
swab
serum
sampl
collect
entri
everi
month
thereaft
blood
sampl
collect
entri
everi
week
thereaft
cird
case
observ
autumn
winter
dog
healthi
arriv
kennel
least
week
develop
clinic
sign
seroconvers
chv
detect
throughout
year
logic
explan
seroconvers
pattern
would
continu
introduct
kennel
acut
infect
dog
reactiv
latent
viru
resid
popul
author
conclud
chv
contribut
cird
oblig
pathogen
environ
sinc
asymptomat
dog
also
seroconvert
kawakami
colleagu
describ
outbreak
infecti
tracheobronch
japan
accompani
death
adult
dog
pathogen
identifi
outbreak
chv
molecular
test
led
conclus
singl
strain
involv
virul
characterist
slightli
higher
previous
test
chv
strain
case
studi
report
erl
colleagu
clear
whether
viru
introduc
center
form
acut
infect
result
reactiv
latent
infect
resid
popul
regardless
author
emphas
suffici
amount
immunosuppress
shelter
popul
allow
chv
signific
primari
pathogen
environ
ocular
manifest
chv
infect
may
develop
primari
recurr
infect
depend
upon
host
age
immun
statu
fetal
neonat
dog
primari
chv
infect
sever
intraocular
lesion
frequent
present
concurr
system
viral
diseas
subclin
mild
recurr
ocular
surfac
diseas
typic
observ
immunocompet
matur
dog
immunosuppress
matur
dog
ocular
lesion
associ
chv
infect
often
sever
persist
longer
durat
may
refractori
treatment
primari
chv
infect
occur
utero
earli
neonat
chv
transmiss
ie
first
week
life
associ
cellassoci
viremia
hematogen
dissemin
viru
result
chv
infect
intraocular
tissu
sever
clinic
ocular
manifest
ocular
diseas
typic
bilater
becom
evid
within
short
period
develop
system
diseas
mani
dog
panuv
retin
optic
neuriti
extens
monocular
neutrophil
infiltr
edema
hemorrhag
necrosi
observ
histopatholog
within
iri
ciliari
bodi
choroid
retina
optic
nerv
intranuclear
viral
inclus
frequent
detect
acut
inflammatori
phase
uveal
retin
tissu
palpebr
fissur
open
day
postpartum
dog
ocular
chang
may
extern
visibl
young
anim
dog
open
eyelid
clinic
detect
ocular
lesion
sequela
panuv
includ
kerat
corneal
edema
aqueou
flare
anterior
synechia
cataract
chorioretin
fig
reduc
vision
blind
may
result
variou
combin
ocular
lesion
follow
acut
inflammatori
stage
infect
development
matur
tissu
eg
cornea
uvea
undergo
vari
degre
necrosi
fibrosi
gliosi
atrophi
canin
retina
incomplet
develop
birth
respond
combin
necrosi
disorgan
reorgan
retin
dysplasia
character
format
retin
fold
rosettelik
structur
retin
degener
final
result
dog
surviv
neonat
chv
infect
blind
cataract
optic
nerv
atrophi
retin
degener
retin
dysplasia
frequent
residu
sequela
contrast
fetal
neonat
dog
ocular
lesion
associ
chv
infect
matur
dog
typic
restrict
ocular
surfac
varieti
corneal
conjunctiv
eyelid
lesion
immunocompet
dog
lesion
frequent
mild
selflimit
howev
sourc
discomfort
recurr
natur
may
frustrat
client
nonspecif
clinic
sign
associ
chv
ocular
infect
matur
dog
includ
blepharospasm
photophobia
ocular
discharg
blepharospasm
ocular
pain
often
disproport
sever
compar
expect
extent
ocular
lesion
ocular
discharg
initi
restrict
epiphora
becom
mucoid
mucopurul
serosanguin
progress
infect
primari
recurr
ocular
chv
infect
may
subclin
associ
variou
combin
blephar
conjunct
kerat
corneal
ulcer
publish
descript
naturallyacquir
primari
ocular
chv
infect
clinic
lesion
bilater
howev
sever
specif
manifest
chv
infect
alway
symmetr
eye
individu
dog
case
primari
ocular
chv
infect
resolv
spontan
without
perman
ocular
lesion
howev
recov
dog
risk
develop
recrudesc
ocular
diseas
associ
reactiv
latent
chv
recrudesc
chv
ocular
diseas
may
present
either
unilater
bilater
lesion
recurr
chv
ocular
infect
may
occur
dog
identifi
risk
factor
howev
immunocompromis
state
present
dog
natur
acquir
recurr
chv
ocular
infect
report
dog
varieti
immunomodul
system
condit
receiv
varieti
immunosuppress
therapeut
system
condit
includ
diabet
mellitu
immunemedi
thrombocytopenia
lymphoma
immunosuppress
therapeut
includ
topic
ocular
corticosteroid
topic
ocular
cyclosporin
system
corticosteroid
varieti
antineoplast
chemotherapeut
eg
cyclophosphamid
doxorubicin
vincristin
mani
report
dog
potenti
immunosuppress
condit
concurr
present
administr
multipl
topic
system
immunosuppress
medic
blephar
occasion
present
ocular
chv
may
appear
focal
gener
eyelid
erythema
edema
exud
crust
region
alopecia
may
present
blephar
may
repres
selftrauma
result
discomfort
associ
conjunctiv
corneal
diseas
activ
viral
infect
eyelid
cutan
epithelium
describ
dermal
region
dog
chv
infect
conjunct
frequent
report
ocular
lesion
associ
primari
recurr
chv
infect
present
conjunctiv
hyperemia
chemosi
ocular
discharg
ulcer
conjunctiv
epithelium
may
occur
appear
flat
irregular
pale
pink
region
conjunctiv
surfac
surround
region
hyperemia
conjunctiv
ulcer
readili
detect
applic
sodium
fluorescein
rose
bengal
lissamin
green
stain
although
clinic
featur
chv
conjunct
often
indistinguish
etiolog
conjunctiv
petechia
frequent
report
dog
chv
infect
fig
although
specif
chv
infect
clinic
find
uncommon
etiolog
conjunct
consid
suggest
chv
ulcer
kerat
nonulc
kerat
frequent
lesion
associ
primari
recurr
ocular
chv
infect
varieti
clinic
manifest
observ
cornea
associ
chv
infect
like
repres
continuum
along
progress
activ
corneal
epitheli
infect
punctat
kerat
earliest
detect
chv
corneal
ulcer
appear
clinic
fine
stippl
epitheli
loss
subtl
lesion
often
clinic
overlook
examin
perform
without
aid
magnif
applic
corneal
vital
stain
particularli
rose
bengal
lissamin
green
facilit
detect
punctat
ulcer
progress
form
classic
alphaherpesviru
corneal
lesion
dendrit
corneal
ulcer
dendrit
corneal
ulcer
strongli
suggest
chv
infect
dog
linear
branch
ulcer
stain
brightli
sodium
fluorescein
rose
bengal
lissamin
green
fig
promin
termin
end
bulb
consist
featur
chv
dendrit
ulcer
dog
use
differenti
chv
corneal
lesion
potenti
caus
linear
corneal
ulcer
might
appear
clinic
similar
eg
extern
trauma
cilia
abnorm
entropion
termin
end
bulb
clubshap
round
end
chv
dendrit
ulcer
branch
seen
caus
linear
corneal
ulcer
coalesc
dendrit
ulcer
may
result
format
geograph
corneal
ulcer
appear
larger
irregularshap
area
corneal
epitheli
loss
dog
chv
ulcer
kerat
corneal
ulcer
commonli
locat
discret
group
linear
arrang
corneal
surfac
unless
complic
secondari
bacteri
infect
chv
corneal
ulcer
remain
superfici
corneal
stromal
loss
appreci
nonulc
kerat
less
frequent
lesion
report
chv
ocular
infect
clinic
nonulc
kerat
appear
circumferenti
ring
cornea
stromal
neovascular
epitheli
subepitheli
leukocyt
infiltr
peripher
cornea
nonulc
kerat
may
repres
resolut
stage
activ
corneal
epitheli
diseas
largest
publish
case
seri
primari
chv
ocular
diseas
describ
outbreak
chv
infect
close
coloni
young
adult
laboratori
beagl
group
dog
conjunct
detect
dog
ulcer
kerat
dog
nonulc
kerat
dog
corneal
ulcer
subclassifi
clinic
appear
punctat
dog
dendrit
dog
geograph
dog
report
confirm
chvassoci
ocular
diseas
group
hous
suscept
dog
provid
overview
spectrum
rel
frequenc
ocular
lesion
associ
primari
ocular
chv
infect
dog
experiment
condit
acquisit
primari
chv
infect
ocular
surfac
inocul
consist
produc
selflimit
conjunct
immunocompet
matur
dog
rout
infect
like
occur
frequent
natur
condit
direct
clinic
relev
viral
inocul
anatom
rout
genit
tract
associ
inconsist
develop
ocular
diseas
clinic
sign
manifest
eye
even
viral
inocul
unilater
magnitud
conjunct
may
symmetr
eye
clinic
sever
ocular
lesion
peak
approxim
day
infect
lesion
slowli
resolv
follow
week
histopatholog
find
dog
acut
experiment
chv
conjunct
includ
conjunctiv
epitheli
necrosi
subepitheli
lymphocyt
macrophag
infiltr
edema
substantia
propria
experiment
induct
recurr
ocular
chv
infect
demonstr
administ
immunosuppress
dosag
system
corticosteroid
latent
infect
dog
recov
primari
chv
ocular
infect
recrudesc
chv
ocular
diseas
detect
immunosuppress
dog
one
studi
bilater
conjunct
linear
corneal
ulcer
develop
earli
day
initi
corticosteroid
administr
mean
durat
detect
ocular
diseas
day
shorter
experiment
primari
ocular
chv
infect
dog
cellular
lesion
observ
vivo
confoc
microscopi
dog
includ
conjunctiv
leukocyt
infiltr
corneal
leukocyt
infiltr
abnorm
corneal
epitheli
cell
morpholog
corneal
langerhan
cell
infiltr
subsequ
research
determin
topic
ocular
corticosteroid
administr
result
recurr
chv
ocular
diseas
latent
infect
dog
experiment
condit
studi
topic
ophthalm
prednisolon
acet
suspens
administ
time
daili
day
eye
dog
experiment
induc
latent
chv
infect
viral
shed
recurr
chv
ocular
diseas
detect
howev
crystallin
corneal
opac
develop
dog
bilater
corneal
lesion
appear
clinic
subepitheli
anterior
stromal
punctat
white
refractil
opac
within
central
cornea
unclear
crystallin
corneal
opac
nonspecif
result
corticosteroid
administr
influenc
prior
chv
corneal
diseas
immunocompromis
dog
lymphoma
receiv
chemotherapi
dog
autoimmun
system
disord
receiv
longterm
immunosuppress
therapi
rel
sever
ocular
lesion
may
develop
recurr
chv
infect
lesion
includ
sever
ulcer
conjunct
extens
corneal
ulcer
refractori
treatment
develop
viremia
system
chv
dissemin
viscer
hemorrhag
necrosi
similar
typic
observ
fetal
neonat
dog
report
matur
dog
ocular
chv
infect
receiv
chemotherapi
lymphoma
report
dog
specul
viremia
system
chv
diseas
develop
secondari
local
ocular
chv
reactiv
insuffici
immun
respons
contain
viru
anatom
site
recurr
diseas
recent
evid
suggest
chv
ocular
diseas
matur
dog
clinic
underappreci
survey
dog
idiopath
conjunct
determin
chv
common
viral
etiolog
conjunct
matur
vaccin
dog
detect
ocular
sampl
approxim
studi
dog
conjunct
among
common
ocular
diseas
dog
present
veterinarian
result
extrapol
gener
canin
popul
impli
chv
ocular
diseas
occur
commonli
determin
site
latenc
chv
miyoshi
colleagu
experiment
inocul
adult
seroneg
dog
via
intranas
n
intranas
intraven
n
intravagin
n
rout
strain
chv
although
clinic
sign
observ
infecti
viru
isol
swab
day
postinocul
tissu
collect
month
postinocul
examin
presenc
latent
viral
dna
determin
trigemin
ganglion
tg
import
latenc
site
chv
regardless
inocul
rout
latenc
detect
also
lumbosacr
ganglia
dog
inocul
intravagin
dog
inocul
intranas
dog
inocul
intranas
intraven
abort
stillbirth
could
also
associ
reactiv
latent
chv
mechan
take
place
investig
retropharyng
lymph
node
anoth
import
latenc
site
sinc
latenc
detect
tissu
dog
convers
attempt
demonstr
latenc
peripher
blood
lymphoid
cell
neg
human
herpesvirus
detect
inner
ear
consid
play
role
vestibular
dysfunct
parzefal
colleagu
report
preval
canin
herpesviru
dna
vestibular
ganglia
vg
vestibular
labyrinth
vl
dog
includ
studi
chv
dna
detect
vl
dog
vg
dog
although
attempt
made
differenti
acut
latent
infect
like
pcr
detect
latent
viru
interestingli
infect
vg
vl
alway
associ
infect
tg
sinc
vg
contrast
trigemin
genicul
ganglia
direct
connect
sensori
nerv
end
bodi
surfac
remain
probabl
primari
infect
tg
genicul
ganglia
subsequ
spread
vg
burr
colleagu
examin
tissu
adult
dog
euthan
variou
reason
dog
tissu
associ
latenc
herpesviru
infect
examin
viral
dna
detect
organ
dog
tissu
commonli
found
posit
lumbosacr
ganglia
tonsil
parotid
salivari
gland
liver
base
data
lumbosacr
ganglia
import
site
latenc
potenti
sourc
reactiv
viru
vener
infect
infect
pup
pass
birth
canal
find
latent
viru
tonsil
salivari
gland
point
role
oronas
spread
transmiss
chv
note
viral
dna
detect
trigemin
ganglia
extract
dog
none
blood
sampl
test
found
posit
indict
lack
detect
viremia
author
comment
chv
either
total
absent
peripher
blood
level
infect
limit
genom
copi
per
mononuclear
cell
also
point
base
incid
chv
infect
serolog
may
lead
underestim
true
infect
rate
difficulti
detect
circul
chv
kennel
situat
highlight
studi
ronss
colleagu
dog
breed
facil
follow
durat
reproduct
cycl
number
dog
seroconvert
neg
posit
chv
period
convers
antibodyposit
dog
becam
seroneg
serolog
data
clearli
indic
chv
circul
kennel
form
acut
andor
reactiv
form
primari
infect
howev
despit
fact
sampl
taken
regular
interv
result
pcr
test
previous
valid
assay
uniformli
neg
nasal
vagin
swab
buffi
coat
sampl
possibl
explan
shed
interv
reactiv
short
even
acut
infect
shed
chv
limit
day
latent
chv
reactiv
treatment
corticosteroid
okuda
colleagu
treat
dam
histori
chv
infect
mg
prednisolon
consecut
day
reactiv
latent
chv
infect
confirm
dam
infecti
chv
recov
nasal
oral
vagin
ocular
secret
day
initi
treatment
also
nasal
mucosa
tonsil
tissu
result
indic
latent
chv
infect
develop
frequent
latent
viru
may
reactiv
without
clinic
sign
dog
histori
chv
infect
ledbett
colleagu
investig
whether
system
administr
immunosuppress
regimen
corticosteroid
mgkgday
consecut
day
experiment
adult
dog
would
lead
reactiv
recrudesc
dog
latent
infect
receiv
corticosteroid
treatment
group
dog
latent
infect
receiv
placebo
group
dog
control
dog
receiv
corticosteroid
treatment
bilater
ocular
diseas
consist
conjunct
kerat
seen
group
dog
day
experi
ocular
shed
detect
group
dog
rise
antibodi
titer
detect
dog
group
none
dog
control
group
show
ocular
diseas
shed
viru
seroconvert
corticosteroidinduc
reactiv
like
result
enhanc
express
viral
cellular
gene
corticosteroid
also
lead
host
immun
respons
suppress
discuss
author
immunosuppress
could
involv
directli
reactiv
event
indirectli
facilit
spread
reactiv
viru
peripher
tissu
lead
renew
replic
peripher
mucos
site
potenti
transmiss
suscept
anim
contact
anim
reactiv
take
place
ledbett
colleagu
also
administ
topic
ocular
prednisolon
acet
placebo
matur
dog
experiment
inocul
chv
via
ocular
rout
previous
test
reactivat
latenc
system
administr
immunosuppress
dose
corticosteroid
dog
treat
time
daili
total
day
result
studi
show
topic
ocular
prednisolon
concentr
treatment
regimen
use
result
detect
reactiv
chv
latenc
base
combin
recrudesc
clinic
sign
confoc
microscopi
find
ocular
infecti
viru
shed
realtim
pcr
find
serolog
respons
potenti
explan
data
concentr
topic
administ
corticosteroid
absorb
system
insuffici
induc
reactiv
malon
colleagu
describ
dissemin
chv
infect
led
euthanasia
adult
dog
dog
undergon
chemotherapi
treatment
gener
lymphoma
clear
whether
gener
infect
case
result
enhanc
suscept
chv
result
immunosuppress
whether
due
reactiv
preexist
latent
chv
infect
dog
amplif
target
sequenc
pcr
method
current
common
sensit
molecular
diagnost
approach
detect
chv
natur
experiment
infect
anim
pcr
assay
describ
initi
gel
base
impli
amplifi
product
visual
uv
illumin
ethidium
bromidestain
agaros
gel
miyoshi
colleagu
combin
nest
pcr
southern
blot
show
detect
limit
combin
equival
tcid
schultz
describ
nest
gelbas
pcr
situ
hybrid
assay
diagnos
acut
chv
infect
formalinfix
paraffinembed
tissu
puppi
natur
infect
specif
pcr
product
confirm
restrict
endonucleas
digest
viral
dna
detect
varieti
cell
type
bronchiolar
alveolar
epitheli
cell
hepatocyt
renal
tubular
epitheli
cell
neuron
fibrocyt
cardiac
myocyt
endotheli
cell
accord
previous
describ
pantrop
chv
paraffinembed
tissu
use
pcr
kept
mind
qualiti
dna
affect
sever
factor
length
time
tissu
remov
fixat
presenc
nucleas
tissu
length
storag
paraffin
block
burr
colleagu
develop
gelbas
pcr
chv
use
conjunct
southern
blot
confirm
authent
amplicon
also
assess
pcr
compat
sampl
chv
pcr
first
verifi
primer
specif
portion
canin
pancreat
lipas
geneamplifi
target
tissu
extract
assay
capabl
detect
approxim
genom
copi
spike
g
placent
dna
approxim
copi
spike
ml
blood
erl
colleagu
describ
gelbas
pcr
target
base
pair
region
gene
homolog
ul
reubel
colleagu
describ
nest
pcr
sensit
time
higher
viru
isol
ronss
colleagu
describ
use
pcr
assay
chv
one
assay
sensit
ccid
sensit
specif
method
current
avail
detect
chv
dna
probebas
realtim
pcr
fluorogen
realtim
pcr
assay
describ
reubel
colleagu
report
detect
limit
copi
viral
dna
first
probebas
multiplex
realtim
pcr
chv
report
ledbett
colleagu
recent
decaro
colleagu
report
develop
complet
valid
probebas
realtim
quantit
pcr
detect
quantit
chv
dna
clinic
sampl
assay
found
sensit
sinc
could
detect
copi
target
per
sampl
comparison
gelbas
pcr
assay
describ
schulz
use
parallel
assay
lower
detect
limit
specif
chv
high
determin
lack
amplif
canin
virus
dynam
rang
valid
success
amplif
number
chvposit
sampl
differ
geograph
locat
reproduc
assay
determin
determin
intraassay
interassay
variabl
result
obtain
sampl
contain
variabl
amount
target
dna
intraassay
interassay
variabl
express
coeffici
variat
fairli
low
depend
target
concentr
found
increas
decreas
target
copi
number
potenti
pitfal
pcr
assay
sampl
contain
substanc
inhibit
reaction
thu
potenti
lead
falseneg
result
control
possibl
intern
control
construct
spike
sampl
known
quantiti
coamplifi
way
inhibit
would
readili
detect
decreas
expect
signal
result
amplif
intern
control
rel
simpl
way
avoid
inhibit
prepar
dilut
sampl
sinc
allow
absolut
quantit
assay
use
determin
viral
load
tissu
pup
die
acut
infect
vagin
swab
collect
dam
viral
load
vagin
swab
l
highest
viral
load
tissu
l
present
kidney
homogen
author
conclud
sinc
quantit
copi
number
wide
rang
assay
use
diagnost
purpos
also
futur
pathogenesi
studi
test
effect
antivir
replic
chv
phrase
carrier
anim
use
extens
describ
anim
harbor
infecti
agent
beyond
usual
time
allow
incub
phase
infect
acut
convalesc
phase
clinic
diseas
come
herpesvirus
problemat
sinc
least
phase
exceed
previous
mention
character
latenc
exacerb
clinic
symptom
latenc
accord
povey
carrier
anim
may
may
shed
viru
excret
secret
shed
may
occur
continu
intermitt
note
preced
section
latenc
strict
definit
lack
viral
transcript
translat
matur
viru
produc
latent
infect
dog
chv
would
defin
carrier
dog
shed
viru
would
contagi
incontact
suscept
dog
exacerb
latent
state
replic
state
would
result
viru
replic
shed
dog
may
mild
sever
clinic
symptom
exacerb
phase
primari
system
neonat
chv
infect
associ
extens
viral
shed
numer
anatom
site
high
chv
viral
titer
detect
respiratori
secret
ocular
discharg
saliva
urin
mani
mucos
surfac
eg
genit
nasal
ocular
oral
pharyng
rectal
tracheal
viral
shed
may
persist
week
dog
surviv
neonat
infect
viral
shed
infect
neonat
may
serv
spread
chv
either
direct
contact
fomit
litterm
dog
primari
recurr
chv
infect
matur
dog
associ
mucos
viral
shed
detect
pcr
assay
viru
isol
durat
anatom
site
shed
vari
markedli
dog
infect
episod
individu
anim
canin
shed
often
occur
multipl
mucos
surfac
simultan
may
detect
site
anatom
distant
region
overt
clinic
diseas
report
experiment
induc
primari
recurr
chv
infect
suggest
viral
shed
primari
infect
prolong
associ
higher
viral
titer
recurr
infect
individu
dog
suscept
chv
reactiv
shed
latent
chv
infect
reactiv
induct
viral
shed
short
durat
corticosteroid
administr
dog
howev
dog
resist
corticosteroidinduc
viral
reactiv
natur
infect
matur
bitch
previous
abort
chvinfect
pup
experiment
immunosuppress
cours
system
corticosteroid
administr
chv
shed
nasal
oral
ocular
vagin
mucosa
viral
shed
could
induc
dog
viral
shed
detect
viru
isol
earli
day
late
day
initi
corticosteroid
administr
durat
detect
chv
shed
rang
day
individu
dog
similar
studi
use
dog
experiment
infect
chv
nasal
intraven
rout
chv
reactiv
mucos
viral
shed
repeatedli
induc
system
corticosteroid
administr
primari
oronas
infect
associ
nasal
chv
shed
approxim
week
durat
follow
recoveri
primari
infect
system
corticosteroid
administr
induc
viral
shed
nasal
oropharyng
genit
mucosa
onset
detect
shed
day
initi
corticosteroid
treatment
persist
day
mark
variat
individu
dog
second
round
corticosteroid
administr
administ
month
later
result
viral
shed
dog
durat
viral
shed
shorter
dog
second
experiment
reactiv
associ
tendenc
lower
viral
titer
studi
examin
ocular
chv
infect
similar
pattern
viral
shed
report
experiment
primari
ocular
chv
infect
matur
dog
produc
direct
ocular
surfac
inocul
result
conjunctiv
viral
shed
persist
day
inocul
viru
detect
conjunctiv
sampl
viru
isol
chv
pcr
viral
titer
peak
day
postinocul
chv
inocul
singl
eye
viral
shed
detect
bilater
dog
follow
recoveri
primari
ocular
infect
viral
shed
detect
subsequ
month
experiment
recurr
ocular
chv
infect
induc
system
corticosteroid
administr
dog
recov
primari
ocular
infect
result
viral
shed
ocular
chv
shed
detect
pcr
assay
dog
day
administ
first
dose
corticosteroid
comparison
primari
ocular
chv
infect
ocular
viral
shed
associ
recurr
infect
briefer
viral
titer
sampl
lower
experiment
primari
chv
genit
mucos
matur
dog
produc
intravagin
intrapreputi
chv
inocul
result
genit
viral
shed
detect
viru
isol
day
sever
dog
also
develop
nasal
pharyng
conjunctiv
viral
shed
period
canin
herpesviru
tracheobronch
induc
intranas
viral
inocul
associ
viral
shed
day
dog
chv
upper
respiratori
tract
infect
viral
shed
nasal
mucosa
detect
viru
isol
dog
concurr
tracheal
rectal
viral
shed
clinic
ecolog
epidemiolog
chv
summar
tabl
basic
start
seri
question
inquir
statu
viru
host
environ
local
critic
question
whether
chv
infect
diseas
econom
concern
mention
earlier
reproduct
diseas
associ
chv
initi
drive
forc
behind
recognit
econom
emot
effect
upon
dog
owner
cost
chvassoci
reproduct
diseas
report
would
conceiv
dam
lose
entir
litter
chv
would
result
loss
sinc
multipl
puppi
involv
case
respiratori
diseas
ocular
diseas
cost
treatment
longterm
care
recurr
infect
may
exceed
per
case
second
question
pertain
zoonot
public
health
risk
associ
chv
infect
viru
speci
specif
evid
support
involv
human
diseas
third
question
key
persist
chv
canin
populationwher
viru
caus
diseas
key
factor
understand
viru
control
viru
maintain
subclin
carrier
dog
way
latenc
may
exacerb
throughout
life
stress
result
mild
sever
clinic
symptom
commonli
affect
respiratori
ocular
system
concurr
clinic
episod
shed
excret
secret
suscept
dog
suscept
age
group
pregnant
chv
dog
puppi
dam
utero
postnat
fourth
question
revolv
around
epidemiolog
chv
infect
occur
suscept
dog
cours
infect
diseas
variabl
review
earlier
contemporari
clinic
observ
one
import
aspect
reiter
import
immun
control
infectiondiseas
process
pregnant
dam
offspr
postnat
period
earli
postnat
infect
week
less
result
high
morbid
accompani
high
mortal
later
infect
week
later
result
low
morbid
low
mortal
howev
usual
later
postnat
infect
establish
lifelong
carrier
state
via
latenc
fifth
question
natur
extens
sequenc
clinic
inquiri
address
control
chv
infect
minim
diseasesuscept
period
maxim
diseaseresist
period
note
previous
shed
state
import
maintain
viru
infect
popul
attain
certain
degre
popul
immun
know
dog
potenti
contagi
maintain
barrier
infect
allow
maximum
protect
suscept
period
sinc
reliabl
vaccin
avail
kennel
hygien
biosecur
essenti
therapi
neonat
chv
infect
larg
support
carri
poor
prognosi
surviv
clinic
diseas
manifest
instanc
dog
surviv
neonat
chv
infect
cardiac
neurolog
ocular
lesion
may
perman
elev
environment
temperatur
dog
litter
chv
infect
diagnos
may
provid
protect
uninfect
pup
viral
replic
reduc
elev
bodi
temperatur
lower
morbid
mortal
rate
dog
subsequ
infect
howev
ineffect
individu
dog
implement
viral
infect
intraperiton
inject
immun
sera
obtain
chvseroposit
dog
describ
method
reduc
mortal
expos
litter
must
administ
prior
infect
effect
lactoferrin
possess
vitro
antivir
activ
chv
inhibit
cellular
infect
administr
lactoferrin
dog
risk
infect
could
theoret
provid
protect
howev
demonstr
vivo
isol
report
appar
success
therapi
neonat
chv
infect
antivir
vidarabin
acyclovir
describ
acyclovir
administ
oral
total
dose
per
dog
interv
week
age
pharmacokinet
tissu
distribut
intraven
subcutan
oral
acyclovir
investig
dog
addit
sustain
releas
buccal
tablet
form
acyclovir
evalu
dog
acyclovir
bioavail
administ
oral
dog
wide
distribut
within
tissu
howev
target
plasma
concentr
effect
dosag
chv
infect
current
unknown
acyclovir
toxicosi
result
accident
ingest
report
dog
dosag
low
mgkg
routin
clinic
use
system
antivir
medic
dog
chv
infect
requir
investig
safeti
efficaci
canin
pharmacokinet
newergener
antiherpesvir
drug
includ
famciclovir
report
similar
acyclovir
safe
effect
dose
dog
chv
infect
undetermin
treatment
respiratori
genit
chv
infect
primarili
symptomat
unless
complic
secondari
bacteri
infect
condit
typic
selflimit
specif
antivir
therapi
report
contrast
respiratori
genit
infect
detail
report
success
clinic
manag
ocular
chv
infect
addit
nonspecif
treatment
prevent
secondari
bacteri
infect
topic
ocular
antimicrobi
improv
comfort
topic
ocular
atropin
antivir
therapi
idoxuridin
trifluridin
ophthalm
solut
use
idoxuridin
trifluridin
nucleosid
analogu
possess
good
antiherpesviru
activ
well
toler
dog
appli
topic
ocular
formul
trifluridin
avail
trade
name
viropt
idoxuridin
acquir
compound
pharmaci
antivir
administ
time
daili
first
hour
time
daili
resolut
clinic
sign
activ
infect
cidofovir
ophthalm
solut
altern
ophthalm
antivir
chv
ocular
diseas
effect
twice
daili
administr
ec
ledbett
unpublish
data
review
document
well
level
clinic
inquiri
expand
knowledg
base
chv
increas
earlier
studi
focus
reproduct
effect
chv
suscept
pregnant
dog
neonat
puppi
becom
appar
order
control
chvrelat
diseas
must
understand
variou
form
chv
infect
may
occur
dog
popul
fig
prompt
veterinari
commun
develop
sensit
diagnost
assay
pcr
order
answer
question
viru
caus
diseas
relationship
respiratori
ocular
diseas
adolesc
adult
dog
year
older
molecular
serolog
studi
clearli
demonstr
deal
infect
common
consid
decad
ago
report
indic
highrisk
dog
popul
infect
latent
carrier
chv
import
veterinarian
know
confer
client
best
manag
step
take
protect
atrisk
popul
pregnant
dam
neonat
puppi
born
dam
consid
high
risk
diseas
must
also
take
consider
dog
kennel
rescu
center
dog
risk
either
exposureinfect
stressinduc
exacerb
latent
chv
acquir
earlier
age
manifest
chv
adolesc
matur
dog
may
rang
subclin
sever
respiratori
andor
ocular
diseas
report
malon
colleagu
gadsden
colleagu
submit
ledbett
colleagu
indic
chv
caus
diseas
older
dog
puppi
diseas
recognit
variou
form
chvinduc
diseas
avail
diagnost
assay
increas
sensit
format
reliabl
biosecur
measur
allow
better
control
step
taken
dog
atrisk
infect
diseas
